LENZ Therapeutics, Inc. (LENZ)
NASDAQ · Healthcare
LENZ Therapeutics, Inc. Shareholder Equity 2024–2025
LENZ Therapeutics, Inc. annual shareholder equity history from 2024 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- LENZ Therapeutics, Inc. shareholder equity as of December 31, 2025: 284.3M, a 39.32% increase year-over-year.
- LENZ Therapeutics, Inc. shareholder equity for 2025 were 284.3M, a 39.32% increase from 2024.
- LENZ Therapeutics, Inc. shareholder equity for 2024 were 204.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| LENZ Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $284 |
| 2024 | $204 |
LENZ Therapeutics, Inc. Shareholder Equity — FAQ
LENZ Therapeutics, Inc. (LENZ) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LENZ's shareholder equity history?
The chart and table above show LENZ Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.